Skip to main content
Caplight Logo









Spirair, Inc.

Spirair, Inc.

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://spirair.com/

Last Round

Series B

Mar 10, 2026

Total Funding Raised

$22.8M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Spirair, Inc. is a medical device company that develops minimally invasive solutions for otolaryngologists to improve patient care for nasal obstruction.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

bioabsorbable implantsotolaryngologyENTnasal airway obstructionseptoplastynasal septal deviationminimally invasive surgerymedical devicesinus surgerybioabsorbablenasal implantsresorbable implantscartilage-sparingambulatory surgery center

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Spirair, Inc. Comparables

Compare Spirair, Inc. with similar companies based on industry and business-model similarity.

Spirair, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aerin Medical
80%
Stryker Corporation
79%
Medtronic
77%

Spirair, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 10, 2026
Series BAug 12, 2025
Series AAug 1, 2021

Key People

Founding team and executive leadership

Benjamin Bishop

Chief Executive Officer

Executive Team

Spirair, Inc. Investors

Notable investors and investment history

Spirair, Inc. investors
InvestorRounds
Cadence Healthcare VenturesSeries B
View VenturesSeries A, Series B
1809 CapitalSeries B
Sonder CapitalSeries A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Grew 23% QoQ, from 26 to 32 employees.

  • Jul 20, 2026

    Open roles increased to 8, 2.1x the trailing average.

Spirair, Inc. Filings

Explore SEC and related filing metadata, where available.

Spirair, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Spirair, Inc.'s valuation, stock price, and market status.

Is Spirair, Inc. a public or private company?

Spirair, Inc. is a private company.

What is the current stock price of Spirair, Inc.?

Spirair, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Spirair, Inc. worth (valuation)?

Valuation information for Spirair, Inc. is not publicly available.

Can I buy Spirair, Inc. stock?

Spirair, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Spirair, Inc.'s last funding round?

Spirair, Inc.'s most recent funding round was Series B on March 10, 2026.

Who are the main investors in Spirair, Inc.?

Key investors in Spirair, Inc. include Cadence Healthcare Ventures, View Ventures, 1809 Capital, Sonder Capital.

Will Spirair, Inc. IPO soon?

No public IPO plans have been announced for Spirair, Inc..

How can I track Spirair, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Spirair, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range20
Year Founded2020
Last FundingMar 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?